These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 30711417)
1. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417 [TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer. Han MS; Lee JM; Kim SN; Kim JH; Kim HS Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542 [TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257 [TBL] [Abstract][Full Text] [Related]
4. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779 [TBL] [Abstract][Full Text] [Related]
5. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy. Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus 16 E6 modulates the expression of host microRNAs in cervical cancer. Ben W; Yang Y; Yuan J; Sun J; Huang M; Zhang D; Zheng J Taiwan J Obstet Gynecol; 2015 Aug; 54(4):364-70. PubMed ID: 26384051 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of HPV 16/18 genotyping and geminin mRNA quantification in low-grade cervical squamous intraepithelial lesion. Zheng Z; Yang X; Yao X; Li L Bioengineered; 2021 Dec; 12(2):11482-11489. PubMed ID: 34874226 [TBL] [Abstract][Full Text] [Related]
10. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6. Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926 [TBL] [Abstract][Full Text] [Related]
11. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas. Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871 [No Abstract] [Full Text] [Related]
12. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Au Yeung CL; Tsang TY; Yau PL; Kwok TT Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis. Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761 [TBL] [Abstract][Full Text] [Related]
14. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study. Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. Vojtechova Z; Sabol I; Salakova M; Smahelova J; Zavadil J; Turek L; Grega M; Klozar J; Prochazka B; Tachezy R BMC Cancer; 2016 Jul; 16():382. PubMed ID: 27377959 [TBL] [Abstract][Full Text] [Related]
18. Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes. Lin L; Cai Q; Zhang X; Zhang H; Zhong Y; Xu C; Li Y Protein Cell; 2015 Aug; 6(8):575-588. PubMed ID: 25913515 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3. Yeung CL; Tsang TY; Yau PL; Kwok TT Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2. Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]